NEW YORK (GenomeWeb) – Researchers from the Genome Institute of Singapore have applied a ChIP-seq method that works on small amounts of input DNA to study epigenetic changes in gastric cancer, identifying hundreds of somatically altered promoters and predicted enhancers, many of which have previously not been seen.

The study was published this month in Nature Communications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.